莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LXRX 莱斯康制药

未开盘 02-18 16:00:00 EST

1.32

+0.00

0.00%

盘后1.40

+0.08+6.06%

19:59 EST

最高1.37	最低1.30	成交量170.80万
今开1.31	昨收1.32	日振幅5.30%
总市值5.52亿	流通市值3.15亿	总股本4.18亿
成交额228.30万	换手率0.71%	流通股本2.39亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LXRX","market":"US","secType":"STK","nameCN":"莱斯康制药","latestPrice":1.32,"timestamp":1771448400000,"preClose":1.32,"halted":0,"volume":1708034,"hourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.32,"latestTime":"19:59 EST","volume":177277,"amount":243711.9285,"timestamp":1771462777448,"change":0.08,"changeRate":0.060606,"amplitude":0.060606},"delay":0,"changeRate":0,"floatShares":239000000,"shares":418000000,"eps":-0.189102,"marketStatus":"未开盘","change":0,"latestTime":"02-18 16:00:00 EST","open":1.31,"high":1.37,"low":1.3,"amount":2283027.9321872,"amplitude":0.05303,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.189102,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771491600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":955080000000,"exchange":"NASDAQ","adjPreClose":1.32,"preHourTrading":{"tag":"盘前","latestPrice":1.3,"preClose":1.32,"latestTime":"09:28 EST","volume":54340,"amount":70679.179428,"timestamp":1771424912527,"change":-0.02,"changeRate":-0.015152,"amplitude":0.022727},"postHourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.32,"latestTime":"19:59 EST","volume":177277,"amount":243711.9285,"timestamp":1771462777448,"change":0.08,"changeRate":0.060606,"amplitude":0.060606},"volumeRatio":0.992729,"impliedVol":1.7804,"impliedVolPercentile":0.768},"requestUrl":"/m/hq/s/LXRX/wiki","defaultTab":"wiki","newsList":[{"id":"1134544869","title":"莱斯康制药公布约9460万美元公开发行及同步私募定价方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1134544869","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134544869?lang=zh_cn&edition=full","pubTime":"2026-01-30 15:51","pubTimestamp":1769759473,"startTime":"0","endTime":"0","summary":"莱斯康制药（Lexicon Pharmaceuticals）已正式确定其公开发行与同步私募融资的最终定价，总规模约为9460万美元。此次融资计划将结合公开市场的股票发售与非公开的定向增发，旨在为公司后续的研发及运营注入新资金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LXRX","BK4139"],"gpt_icon":0},{"id":"1158075687","title":"莱斯康制药与FDA就Pilavapadin治疗糖尿病周围神经病变性疼痛完成二期临床试验末次会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1158075687","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158075687?lang=zh_cn&edition=full","pubTime":"2026-01-21 21:31","pubTimestamp":1769002304,"startTime":"0","endTime":"0","summary":"莱斯康制药宣布，其针对糖尿病周围神经病变性疼痛的候选药物Pilavapadin，已顺利完成与美国食品药品监督管理局（FDA）的二期临床试验末次会议。此次会议标志着该药物研发进程中的重要里程碑，为后续临床研究计划的推进奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX","BK4007"],"gpt_icon":0},{"id":"2595763875","title":"莱斯康制药盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595763875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595763875?lang=zh_cn&edition=full","pubTime":"2025-12-30 03:36","pubTimestamp":1767037004,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日03时36分，莱斯康制药股票出现异动，股价急速下挫5.28%。截至发稿，该股报1.17美元/股，成交量104.767万股，换手率0.29%，振幅3.66%。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Nutriband Inc C/Wts 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Theriva Biologics, Inc.、Indaptus Therapeutics, Inc.、Mereo Biopharma Group Plc较为活跃，换手率分别为359.23%、272.71%、128.62%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为73.40%、61.49%、59.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230033644a6de1cf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230033644a6de1cf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4007","BK4139"],"gpt_icon":0},{"id":"1155538128","title":"2025心血管临床试验论坛将发布Sotagliflozin在非糖尿病患者中对脂肪分布影响的临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1155538128","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155538128?lang=zh_cn&edition=full","pubTime":"2025-12-05 21:30","pubTimestamp":1764941414,"startTime":"0","endTime":"0","summary":"2025心血管临床试验论坛将发布Sotagliflozin在非糖尿病患者中对脂肪分布影响的临床数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","LXRX"],"gpt_icon":0},{"id":"1160642383","title":"莱斯康制药提交最高达7500万美元普通股发售申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1160642383","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160642383?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:02","pubTimestamp":1763571735,"startTime":"0","endTime":"0","summary":"11月7日 - 莱斯康制药 :: 莱斯康制药提交最高达7500万美元普通股发售申请 - SEC 文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX","BK4007"],"gpt_icon":0},{"id":"1174691635","title":"莱斯康制药第三季度每股收益为-0.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174691635","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174691635?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571440,"startTime":"0","endTime":"0","summary":"11月6日 — 莱斯康制药第三季度基本每股收益为-0.04美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX","BK4007"],"gpt_icon":0},{"id":"2582227804","title":"莱斯康制药盘中异动 股价大涨5.20%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582227804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582227804?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:59","pubTimestamp":1762786796,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时59分，莱斯康制药股票出现异动，股价急速上涨5.20%。截至发稿，该股报1.32美元/股，成交量58.0686万股，换手率0.16%，振幅4.80%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.77%。消息层面，截至22时59分，《花旗维持莱斯康制药买入评级，维持目标价1.9美元》资讯为影响莱斯康制药的重要信息。根据TipRanks数据显示，该分析师近一年总胜率为41.7%，总平均回报率为5.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110225956a6efcaac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110225956a6efcaac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LXRX"],"gpt_icon":0},{"id":"2581533868","title":"莱斯康制药盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581533868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581533868?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:46","pubTimestamp":1762526801,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时46分，莱斯康制药股票出现波动，股价快速跳水5.24%。截至发稿，该股报1.36美元/股，成交量39.2913万股，换手率0.11%，振幅3.85%。机构评级方面，在所有5家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.62%。莱斯康制药公司简介：莱斯康制药有限公司是一家生物制药公司，从事用于治疗人类疾病的药品的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107224641a4909192&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107224641a4909192&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":1},{"id":"2573988054","title":"莱斯康制药盘中异动 快速拉升5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573988054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573988054?lang=zh_cn&edition=full","pubTime":"2025-10-06 22:09","pubTimestamp":1759759749,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日22时09分，莱斯康制药股票出现波动，股价急速上涨5.67%。截至发稿，该股报1.49美元/股，成交量83.3328万股，换手率0.23%，振幅3.55%。机构评级方面，在所有5家参与评级的机构中，60%的券商给予买入建议，40%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.11%。莱斯康制药公司简介：莱斯康制药有限公司是一家生物制药公司，从事用于治疗人类疾病的药品的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100622091097218b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100622091097218b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2572562045","title":"莱斯康制药盘中异动 股价大涨5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572562045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572562045?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:38","pubTimestamp":1759325880,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日21时38分，莱斯康制药股票出现异动，股价急速拉升5.19%。截至发稿，该股报1.42美元/股，成交量39.6194万股，换手率0.11%，振幅5.93%。莱斯康制药股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Palisade Bio, Inc.、Alpha Cognition Inc.涨幅较大，Palisade Bio, Inc.、Scisparc Ltd.、Soligenix, Inc.较为活跃，换手率分别为183.16%、11.04%、10.41%，振幅较大的相关个股有Palisade Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Leap Therapeutics, Inc.，振幅分别为23.26%、15.04%、13.22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100121380094b73abf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100121380094b73abf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":1},{"id":"1169702810","title":"莱斯康制药宣布向美国FDA提交额外数据以支持Zynquista®在1型糖尿病治疗中获益风险评估的最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1169702810","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169702810?lang=zh_cn&edition=full","pubTime":"2025-09-23 04:00","pubTimestamp":1758571216,"startTime":"0","endTime":"0","summary":"莱斯康制药宣布向美国FDA提交额外数据以支持Zynquista®在1型糖尿病治疗中获益风险评估的最新进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"1187738885","title":"Pilavapadin在欧洲糖尿病研究协会(EASD)和Neurodiab年会上发表的数据显示，该药物能为成人糖尿病周围神经病变疼痛(DPNP)患者带来显著的疼痛缓解效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1187738885","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187738885?lang=zh_cn&edition=full","pubTime":"2025-09-17 19:01","pubTimestamp":1758106882,"startTime":"0","endTime":"0","summary":"Pilavapadin在欧洲糖尿病研究协会(EASD)和Neurodiab年会上发表的数据显示，该药物能为成人糖尿病周围神经病变疼痛(DPNP)患者带来显著的疼痛缓解效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"1188404725","title":"莱斯康制药宣布向美国FDA提交支持Zynquista®在1型糖尿病治疗中效益风险概况的额外数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1188404725","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188404725?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:30","pubTimestamp":1757334620,"startTime":"0","endTime":"0","summary":"莱斯康制药宣布向美国FDA提交支持Zynquista®在1型糖尿病治疗中效益风险概况的额外数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139"],"gpt_icon":0},{"id":"2564235913","title":"莱斯康制药盘中异动 早盘股价大涨5.91%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564235913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564235913?lang=zh_cn&edition=full","pubTime":"2025-09-02 21:36","pubTimestamp":1756820188,"startTime":"0","endTime":"0","summary":"北京时间2025年09月02日21时36分，莱斯康制药股票出现波动，股价大幅上涨5.91%。截至发稿，该股报1.17美元/股，成交量51.7541万股，换手率0.14%，振幅4.09%。莱斯康制药股票所在的生物技术行业中，整体涨幅为0.64%。公司的一些候选药物是LX9211，一种口服小分子候选药物，同时也在开发LX9851，另一种口服小分子候选药物，用于治疗肥胖和相关的心脏代谢。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902213629a70bb85f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902213629a70bb85f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"1123212761","title":"在欧洲心脏病学会(ESC) 2025年大会上发布的数据显示，索格列净在各年龄段（包括75岁以上）心力衰竭和主要心血管事件方面提供一致的相对风险降低效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1123212761","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123212761?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:30","pubTimestamp":1756816252,"startTime":"0","endTime":"0","summary":"在欧洲心脏病学会(ESC) 2025年大会上发布的数据显示，索格列净在各年龄段（包括75岁以上）心力衰竭和主要心血管事件方面提供一致的相对风险降低效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2518522222","title":"莱斯康制药盘中异动 早盘急速下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518522222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518522222?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613563,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，莱斯康制药股票出现波动，股价大幅跳水5.56%。截至发稿，该股报0.370美元/股，成交量48.2552万股，换手率0.13%，振幅5.10%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213243abf2fc93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213243abf2fc93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0},{"id":"2518897552","title":"莱斯康制药2024财年实现净利润-2.00亿美元，同比减少12.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518897552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518897552?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536075,"startTime":"0","endTime":"0","summary":"3月10日，莱斯康制药公布财报，公告显示公司2024财年净利润为-2.00亿美元，同比减少12.99%；其中营业收入为31.08百万美元，同比增加2490.00%，每股基本收益为-0.63美元。从资产负债表来看，莱斯康制药总负债1.52亿美元，其中短期债务1.18百万美元，资产负债比为1.97，流动比率为0.06。机构评级：截至2025年3月10日，当前有4家机构对莱斯康制药目标价做出预测，其中目标均价为2.95美元，其中最低目标价为0.80美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000235a268986e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000235a268986e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX"],"gpt_icon":1},{"id":"2517613251","title":"莱斯康制药盘中异动 早盘大幅上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517613251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517613251?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:48","pubTimestamp":1741272507,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时48分，莱斯康制药股票出现异动，股价快速拉升5.15%。截至发稿，该股报0.353美元/股，成交量98.0654万股，换手率0.27%，振幅7.08%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，43%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体跌幅为0.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224827963c50db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224827963c50db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LXRX","BK4139"],"gpt_icon":1},{"id":"2517599941","title":"莱斯康制药盘中异动 快速上涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517599941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517599941?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:55","pubTimestamp":1741190111,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时55分，莱斯康制药股票出现波动，股价快速上涨5.51%。截至发稿，该股报0.343美元/股，成交量228.905万股，换手率0.63%，振幅9.24%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，43%的券商给予持有建议，无券商给予卖出建议。莱斯康制药股票所在的生物技术行业中，整体涨幅为1.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235511989d59d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305235511989d59d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LXRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lexpharma.com","stockEarnings":[{"period":"1week","weight":-0.0365},{"period":"1month","weight":-0.0365},{"period":"3month","weight":0},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.7305},{"period":"ytd","weight":0.1478}],"compareEarnings":[{"period":"1week","weight":-0.0082},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1223},{"period":"ytd","weight":0.0064}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lexicon Pharmaceuticals, Inc.是一家生物制药公司，专注于研究并实现人类疾病在治疗上的突破。通过基因敲除技术和先进的医疗技术综合平台，该公司已经系统研究了小白鼠体内近5000个基因的生理和行为功能，且评估了由相应的人类基因作为潜在药物靶标所编码的蛋白质的效用，并且已经在活体（或活的有机体）内确定并验证了100多个能很好地应用于药物发现的靶标。对于那些被认定有很高药用价值的靶标，其致力于对潜在新药物的研制计划。该公司于1995年7月7日在美国特拉华州成立，并于1995年9月开始营运。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.040884},{"month":2,"riseRate":0.423077,"avgChangeRate":-0.051596},{"month":3,"riseRate":0.48,"avgChangeRate":-0.019425},{"month":4,"riseRate":0.44,"avgChangeRate":0.012763},{"month":5,"riseRate":0.5,"avgChangeRate":0.029091},{"month":6,"riseRate":0.653846,"avgChangeRate":0.134775},{"month":7,"riseRate":0.5,"avgChangeRate":0.021487},{"month":8,"riseRate":0.269231,"avgChangeRate":-0.025279},{"month":9,"riseRate":0.346154,"avgChangeRate":0.011129},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.006481},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.041818},{"month":12,"riseRate":0.461538,"avgChangeRate":0.062158}],"exchange":"NASDAQ","name":"莱斯康制药","nameEN":"Lexicon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱斯康制药(LXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱斯康制药,LXRX,莱斯康制药股票,莱斯康制药股票老虎,莱斯康制药股票老虎国际,莱斯康制药行情,莱斯康制药股票行情,莱斯康制药股价,莱斯康制药股市,莱斯康制药股票价格,莱斯康制药股票交易,莱斯康制药股票购买,莱斯康制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱斯康制药(LXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱斯康制药(LXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}